SCRS Talks

The Covid-19 pandemic caught everyone by surprise. Now that some time has passed and we are acclimating to the current climate, what should sites be thinking about when it comes to risk management and insurance?   This is not just an insurance discussion - it’s a discussion about risk. This includes the increased use of telemedicine and prevalence of decentralized clinical trials. This final inter...

It pays to be prepared, especially in uncertain times. As sites struggle to maintain patient visits and keep trials moving forward amidst COVID-19, many are turning to remote monitoring and other elements of decentralized clinical trials (DCTs) to ensure their doors stay open. This SCRS Talks interview with Global Impact Partner (GIP) VirTrial provides insight into how sites can prepare to partici...

The COVID-19 pandemic is a serious situation requiring careful navigation, and many companies associated with clinical trials are struggling to keep their doors open. How am I going to survive the next few months? What questions do I need to be asking? Who can I rely on for accurate information and guidance? Learn from Hylant as they sit down with SCRS to discuss how this is impacting sites, speci...